Table 1. Baseline characteristics of patients.

Variable	Salvianolate (n=262)	Placebo (n=265)	P value
Age, y	61.1±12.7	62.4±11.3	0.6055
Female	16.4 [43]	18.1 [48]	0.2043
Body mass index	24.5±3.2	24.0±3.1	0.0806
Hypertension	50.0 [131]	54.0 [143]	0.3627
Hypercholesterolemia	8.4 [22]	9.8 [26]	0.5726
Diabetes mellitus	25.2 [66]	23.0 [61]	0.5600
History of angina	6.5 [17]	7.5 [20]	0.5787
Peripheral artery disease	0.8 [2]	1.1 [3]	0.5445
Previous stroke
Ischemic stroke	2.7 [7]	3.0 [8]	0.8106
Hemorrhagic stroke	0.8 [2]	0.8 [2]	0.9909
Symptom to door time	5.4±2.7	5.3±2.7	0.5634
Infarct site (ECG)
Anterior	49.2 [129]	52.9 [139]	0.4070
Other sites	50.8 [133]	47.1 [124]
Blood pressure, mmHg
Systolic blood pressure	129.2±22.5	130.1±20.5	0.6551
Diastolic blood pressure	78.7±14.9	79.3±13.8	0.6610
Heart rate, beats/min	78.0±14.4	78.3±14.6	0.8416
Admission creatinine kinase, U/L	70.94±105.67	69.99±99.34	0.5973

ECG, electrocardiogram.